发明名称 2,4-PYRIMIDINEDIAMINE USEFUL IN TREATMENT OF NEOPLASTIC DISEASE, INFLAMMATORY AND IMMUNE SYSTEM DISORDER
摘要 PROBLEM TO BE SOLVED: To provide new pyrimidine derivatives, some types of the new pyrimidine derivatives, their production method, their use as pharmaceuticals, and pharmaceutical compositions comprising them. SOLUTION: The pyrimidine derivatives are expressed by formula I [wherein R is selected from 6-10C aryl, 5-10C heteroaryl, 3-12C cycloalkyl and 3-10C heterocycloalkyl; and R<SP>0</SP>-R<SP>6</SP>are as defined specifically]. The compounds of formula I are used for production of pharmaceuticals for treating diseases responding to inhibition of FAK and/or ALK and/or ZAP-70 and/or IGF-IR. COPYRIGHT: (C)2011,JPO&amp;INPIT
申请公布号 JP2010241830(A) 申请公布日期 2010.10.28
申请号 JP20100162177 申请日期 2010.07.16
申请人 NOVARTIS AG;IRM LLC 发明人 GARCIA-ECHEVERRIA CARLOS;KANAZAWA TAKAKI;KAWAHARA EIJI;MASUYA KEIICHI;MATSUURA NAOKO;MIYAKE TAKAHIRO;OMORI OSAMU;UMEMURA ICHIRO;STEENSMA RUO;CHOPIUK GREG;JIANG JIQING;WAN YONGQIN;QUIAN DING;ZHANG QIONG;GRAY NATHANAEL SCHIANDER;KARANEWSKY DONALD
分类号 A61K31/505;A61K31/438;A61K31/506;A61K31/5377;A61K31/5383;A61K31/541;A61P1/04;A61P1/16;A61P3/10;A61P5/14;A61P9/00;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P17/00;A61P17/04;A61P17/06;A61P19/00;A61P19/02;A61P21/00;A61P21/04;A61P25/00;A61P25/28;A61P27/02;A61P29/00;A61P31/00;A61P31/04;A61P31/18;A61P35/00;A61P37/00;A61P37/06;A61P37/08;A61P43/00;C07D239/48;C07D239/50;C07D401/12;C07D401/14;C07D403/12;C07D403/14;C07D405/12;C07D405/14;C07D417/12;C07D491/113;C07D498/04 主分类号 A61K31/505
代理机构 代理人
主权项
地址